CA962593A - Highly attenuated newcastle disease virus vaccine and production thereof - Google Patents

Highly attenuated newcastle disease virus vaccine and production thereof

Info

Publication number
CA962593A
CA962593A CA099,281A CA99281A CA962593A CA 962593 A CA962593 A CA 962593A CA 99281 A CA99281 A CA 99281A CA 962593 A CA962593 A CA 962593A
Authority
CA
Canada
Prior art keywords
production
disease virus
virus vaccine
newcastle disease
highly attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA099,281A
Other versions
CA99281S (en
Inventor
Homu Ito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of CA962593A publication Critical patent/CA962593A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA099,281A 1969-11-29 1970-11-27 Highly attenuated newcastle disease virus vaccine and production thereof Expired CA962593A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9581969 1969-11-29

Publications (1)

Publication Number Publication Date
CA962593A true CA962593A (en) 1975-02-11

Family

ID=14148007

Family Applications (1)

Application Number Title Priority Date Filing Date
CA099,281A Expired CA962593A (en) 1969-11-29 1970-11-27 Highly attenuated newcastle disease virus vaccine and production thereof

Country Status (7)

Country Link
CA (1) CA962593A (en)
DE (1) DE2058645C2 (en)
DK (1) DK124340B (en)
ES (1) ES385968A1 (en)
FR (1) FR2073436B1 (en)
GB (1) GB1274820A (en)
NL (1) NL170595C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102268410A (en) * 2011-06-17 2011-12-07 湖北省农业科学院畜牧兽医研究所 Newcastle disease virus heat-resistant attenuated strain adapted to baby hamster kidney passage cell and preparation method and application thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU826584A1 (en) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Vaccine against newcastle fowl disease, process for preparing the same and method for prophylaxis of newcastle fowl diease
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
ES2619936T3 (en) 2004-11-05 2017-06-27 Wellstat Biologics Corporation Stable and filterable enveloped virus formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2767117A (en) * 1953-10-22 1956-10-16 Crawley John Frederick Poultry virus vaccine products and method of preparing the same
GB1010509A (en) * 1962-02-23 1965-11-17 Pfizer Ltd Improvements in or relating to newcastle disease virus vaccines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102268410A (en) * 2011-06-17 2011-12-07 湖北省农业科学院畜牧兽医研究所 Newcastle disease virus heat-resistant attenuated strain adapted to baby hamster kidney passage cell and preparation method and application thereof

Also Published As

Publication number Publication date
ES385968A1 (en) 1973-11-16
NL7017334A (en) 1971-06-02
GB1274820A (en) 1972-05-17
NL170595C (en) 1982-12-01
NL170595B (en) 1982-07-01
DK124340B (en) 1972-10-09
FR2073436A1 (en) 1971-10-01
FR2073436B1 (en) 1974-08-30
DE2058645A1 (en) 1971-06-09
DE2058645C2 (en) 1982-02-11

Similar Documents

Publication Publication Date Title
CA962593A (en) Highly attenuated newcastle disease virus vaccine and production thereof
AU454379B2 (en) Highly attenuated newcastle disease virus vaccine and production thereof
AU2275770A (en) Highly attenuated newcastle disease virus vaccine and production thereof
CA943063A (en) Calf diarrhea virus vaccine and processes
CA950358A (en) Vaccines
AU2183370A (en) Multivalent vaccines and process for their preparation
CA957279A (en) Vaccine preparation
IE35695B1 (en) Virus preparation
CA940925A (en) Chalcone derivatives and preparation thereof
AU451635B2 (en) Vaccine preparation
AU456693B2 (en) Improvements; in virus vaccines
CA956232A (en) Attenuated live rubella virus vaccine and method of production
IT1048893B (en) SMOKE PREPARATION
AU440195B2 (en) Vaccine preparation
CA970278A (en) Veterinary vaccine
CA813864A (en) Influenza virus sub-unit vaccine
CA839228A (en) Vaccine and its preparation
CA818456A (en) Influenza vaccines and process for their manufacture
AU1683070A (en) Vaccine preparation
CA892576A (en) Aminolignosulfonates and preparation thereof
CA862070A (en) Inactivated virus vaccine and process for producing same
CA811119A (en) Rabies vaccine and process for preparation thereof
AU446673B2 (en) Insect virus replication and product
CA812760A (en) Vaccine process and product
CA822640A (en) Inactivated hog cholera vaccine